Valion Bio, Inc.
Pharmaceutical company · San Antonio, Texas, United States · Nasdaq: VBIO
Valion Bio, Inc. is a pharmaceutical company headquartered in San Antonio, Texas, United States. Its earliest recorded incorporation is in 2016. Its shares trade on Nasdaq under the ticker VBIO. It has reported private securities offerings to the US SEC, most recently $12 million sold in a notice filed in 2025.
Valion Bio at a glance
What does Valion Bio do?
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $12 million sold (2025).
Frequently asked questions about Valion Bio
Where is Valion Bio headquartered?
Valion Bio, Inc. is headquartered in San Antonio, Texas, United States.
What does Valion Bio do?
Valion Bio, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Valion Bio a public company?
Yes. Valion Bio, Inc. trades on Nasdaq under the ticker VBIO.
When was Valion Bio founded?
The earliest incorporation on record for Valion Bio, Inc. is in 2016, according to public company registers.
Similar companies
- Evestra IncSan Antonio, Texas, United States
- Scorpius Holdings, Inc.San Antonio, Texas, United States
- Rapamycin Holdings, Inc.San Antonio, Texas, United States
- Viroxis CorpSan Antonio, Texas, United States
- Phoenix Biotechnology IncSan Antonio, Texas, United States
- Nerium Biotechnology IncSan Antonio, Texas, United States
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-24. Data licences